Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  homocysteine
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Introduction: Meningomyelocele (MMC) is the most severe form of spina bifida caused by both genetic and environmental components. It is well known that status of folate plays an important role in the risk of neural tube defects. High homocysteine (Hc) level may be associated with disturbed sensory and motor peripheral nerve function and is lowering after folic acid (FA) fortification. Purpose: To explore possible links of FA (folic acid) and Hc (Homocysteine) and to correlate them with renal and bladder function (based on urodynamics) as well as physical activity in patients with NB (neurogenic bladder) after MMC (myelomeningocele). Materials and methods: The investigation was conducted on two groups: group 1- 30 children with neurogenic bladder, group 2 - 20 healthy children with no abnormalities in urinary and nervous systems. The Hc concentration in urine and serum was estimated using the ELISA set and FA was measured in serum using electro-chemiluminescence method. FA/Hc ratio was calculated in all children. Results: The median serum and urine Hc were higher compared with reference group. Median FA/Hc ratio was statistically significantly lower in MMC group compared to reference group. There were no differences in serum FA between studied groups. We found statistically significant correlations between urodynamics parameters and FA and Hc. Conclusions: Hyperhomocyteinemia and hyper-homocysteinuria could be considered as factors influencing bladder function in MMC patients. Although serum FA level was in normal range in MMC patients it does not exclude disturbed folic acid status.
PL
Wstęp: Ponieważ ołów wywołuje stres oksydacyjny, przypuszcza się, że antyoksydanty mogą mieć zastosowanie w leczeniu zatrucia tym metalem. Celem niniejszej pracy było zbadanie, czy podawanie β-karotenu redukuje stres oksydacyjny oraz obniża stężenie homocysteiny u pracowników narażonych na ołów. Materiał i metody: Grupę badaną stanowili zdrowi pracownicy płci męskiej podzieleni na 2 podgrupy (średnie stężenie ołowiu we krwi: ok. 44 μg/dl). W pierwszej (N = 49, grupa porównawcza) nie stosowano żadnego leczenia, a drugiej podawano β-karoten w dawce 10 mg na dzień przez 12 tygodni. Analiza biochemiczna objęła markery narażenia na ołów i marker stresu oksydacyjnego - dialdehyd malonowy (malondialdehyde - MDA). Ponadto zbadano stężenie homocysteiny (homocysteine - Hcy), grup tiolowych oraz aktywność dysmutazy ponadtlenkowej (superoxide dismutase - SOD) i jej izoenzymu EC-SOD. Wyniki: Po suplementacji w grupie leczonej zaobserwowano obniżenie się stężenia MDA w porównaniu z wartościami wyjściowymi oraz z wynikami w grupie porównawczej. Obniżeniu uległo także stężenie Hcy w porównaniu z wynikami uzyskanymi dla grupy porównawczej. Z kolei stężenie grup tiolowych oraz aktywność SOD uległy zwiększeniu w porównaniu z grupą porównawczą, a w przypadku SOD i EC-SOD także w porównaniu z wartościami wyjściowymi. Wnioski: Wyniki niniejszego badania sugerują, że podawanie β-karotenu w zatruciu ołowiem może przynieść korzyści, takie jak zmniejszenie stresu oksydacyjnego, mierzonego pośrednio jako stężenie MDA, lub obniżenie stężenia aterogennej homocysteiny. Med. Pr. 2014;65(3):309–316
EN
Background: Oxidative stress is involved in lead toxicity. This suggests that some antioxidants may play a role in the treatment of lead poisoning. In the light of this, the aim of the study was to determine whether β-carotene administration reduces oxidative stress and homocysteine level in workers chronically exposed to lead. Material and Methods: The exposed population included healthy male workers exposed to lead who were randomly divided into 2 groups (mean blood lead level ca. 44 μg/dl). Workers in the 1st group (N = 49, reference group) had no antioxidants, drugs, vitamins or dietary supplements administered, while workers in the 2nd group (N = 33) had β-carotene administered in a dose of 10 mg per day for 12 weeks. Biochemical analysis included markers of lead-exposure and the level of malondialdehyde (MDA), an oxidative stress biomarker. We also measured the level of homocysteine (Hcy) and thiol groups as well as the activity of superoxide dismutase (SOD) and its isoenzyme EC-SOD in serum. Results: After supplementation, the level of MDA significantly decreased, compared to baseline, by 16%, and to the reference group. When compared to the reference group, Hcy level was also significantly decreased. However, the level of thiol groups was significantly higher after supplementation with β-carotene compared to the reference group. Analogically, the activity of SOD and EC-SOD was significantly higher compared to the baseline and to the reference group. Conclusions: Despite some controversies over antioxidant properties of β-carotene, our results indicate that its antioxidant action could provide some beneficial effects in lead poisoning independent of chelation. Med Pr 2014;65(3):309–316
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.